{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:53:21Z","timestamp":1788252801502,"version":"build-2803163510"},"reference-count":102,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Neurol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cannabinoid use, particularly for recreational purposes, is increasing exponentially across all age groups, especially in younger populations, due to its perceived low risk and legalization. While cannabinoids may be largely considered as safe, there is mounting evidence of increased risk of systemic and neurological complications through their interaction with the poorly understood endocannabinoid receptor network within the central nervous system and other organ systems. Acute cannabinoid exposure can cause neuropsychiatric symptoms in addition to altering cerebral blood flow, leading to cerebrovascular complications such as ischemic stroke, subarachnoid hemorrhage, and reversible cerebral vasoconstriction syndrome (RCVS). Chronic use, particularly among adolescents, may be associated with increased risk of long-term cognitive deficits, schizophrenia, and other neuropsychiatric effects. Synthetic cannabinoids have increased potency, with reports of causing profound neurological complications including coma, seizures, posterior reversible encephalopathy syndrome, and RCVS. Despite increasing evidence, the quality of literature describing neurologic complications with cannabinoids remains limited to case series and retrospective cohort studies, with significant confounding factors such as concomitant use of other illicit drugs, limiting interpretation. In this review, we summarize the effect of cannabinoids on the neurologic system and associated neurological complications.<\/jats:p>","DOI":"10.1055\/s-0044-1787570","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T19:00:25Z","timestamp":1719255625000},"page":"430-440","source":"Crossref","is-referenced-by-count":3,"title":["Neurological Complications of Cannabinoids"],"prefix":"10.1055","volume":"44","author":[{"given":"Mariyam","family":"Humayun","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Illinois, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose I.","family":"Suarez","sequence":"additional","affiliation":[{"name":"Departments of Neurology, Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishank A.","family":"Shah","sequence":"additional","affiliation":[{"name":"Departments of Neurology, Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"key":"ref4","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3389\/fphar.2019.01481","article-title":"Harmful effects of smoking cannabis: a cerebrovascular and neurological perspective","volume":"10","author":"S R Archie","year":"2019","journal-title":"Front Pharmacol"},{"issue":"05","key":"ref5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn.2016.28","article-title":"Keep off the grass? Cannabis, cognition and addiction","volume":"17","author":"H V Curran","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"07","key":"ref6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"H C Lu","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/metabo13030442","article-title":"Biosynthesis of phytocannabinoids and structural insights: a review","volume":"13","author":"R K Govindarajan","year":"2023","journal-title":"Metabolites"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"L Cristino","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","article-title":"Modulation of transmitter release via presynaptic cannabinoid receptors","volume":"22","author":"E Schlicker","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fncel.2016.00294","article-title":"Cannabinoid receptors in the central nervous system: Their signaling and roles in disease","volume":"10","author":"D A Kendall","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09540260902782752","article-title":"Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence","volume":"21","author":"Z D Cooper","year":"2009","journal-title":"Int Rev Psychiatry"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awg143","article-title":"Cannabis and the brain","volume":"126","author":"L Iversen","year":"2003","journal-title":"Brain"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fpubh.2018.00162","article-title":"Synthetic and non-synthetic cannabinoid drugs and their adverse effects-a review from public health prospective","volume":"6","author":"K Cohen","year":"2018","journal-title":"Front Public Health"},{"issue":"11","key":"ref14","first-page":"CD009464","article-title":"Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy","volume":"2015","author":"L A Smith","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"ref15","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"P F Whiting","year":"2015","journal-title":"JAMA"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1476-5381.2010.01176.x","article-title":"Regulation of nausea and vomiting by cannabinoids","volume":"163","author":"L A Parker","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamaneurol.2020.0073","article-title":"Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in dravet syndrome: a randomized clinical trial","volume":"77","author":"I Miller","year":"2020","journal-title":"JAMA Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"E A Thiele","year":"2018","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"586110","DOI":"10.3389\/fphar.2020.586110","article-title":"Cannabidiol treatment for refractory epilepsies in pediatrics","volume":"11","author":"U Raucci","year":"2020","journal-title":"Front Pharmacol"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"F M Leweke","year":"2012","journal-title":"Transl Psychiatry"},{"issue":"06","key":"ref21","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"M M Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/14737175.2022.2161894","article-title":"Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry","volume":"22","author":"S Mangoo","year":"2022","journal-title":"Expert Rev Neurother"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3934\/Neuroscience.2021022","article-title":"Cannabis in the management of PTSD: a systematic review","volume":"8","author":"Y Rehman","year":"2021","journal-title":"AIMS Neurosci"},{"issue":"03","key":"ref24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/archinte.167.3.221","article-title":"Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review","volume":"167","author":"J M Tetrault","year":"2007","journal-title":"Arch Intern Med"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of Tourette's syndrome with \u0394 9-tetrahydrocannabinol (THC): a randomized crossover trial","volume":"35","author":"K R M\u00fcller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/104990910101800411","article-title":"Marijuana in the management of amyotrophic lateral sclerosis","volume":"18","author":"G T Carter","year":"2001","journal-title":"Am J Hosp Palliat Care"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JPD-212923","article-title":"Effects of cannabis in Parkinson's disease: a systematic review and meta-analysis","volume":"12","author":"B Urbi","year":"2022","journal-title":"J Parkinsons Dis"},{"issue":"25","key":"ref29","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.2174\/13816128113199990620","article-title":"Acute and long-term effects of cannabis use: a review","volume":"20","author":"L Karila","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.amjcard.2013.09.042","article-title":"Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know","volume":"113","author":"G Thomas","year":"2014","journal-title":"Am J Cardiol"},{"issue":"23","key":"ref31","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/01.CIR.103.23.2805","article-title":"Triggering myocardial infarction by marijuana","volume":"103","author":"M A Mittleman","year":"2001","journal-title":"Circulation"},{"issue":"02","key":"ref32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s41030-021-00171-8","article-title":"Cannabis and lung health: does the bad outweigh the good?","volume":"7","author":"A G Kaplan","year":"2021","journal-title":"Pulm Ther"},{"issue":"49","key":"ref33","doi-asserted-by":"crossref","first-page":"e32111","DOI":"10.1097\/MD.0000000000032111","article-title":"Review of systemic and syndromic complications of cannabis use: a review","volume":"101","author":"J Shah","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/15412555.2012.671868","article-title":"Impact of changes in regular use of marijuana and\/or tobacco on chronic bronchitis","volume":"9","author":"D P Tashkin","year":"2012","journal-title":"COPD"},{"issue":"631","key":"ref35","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.3399\/bjgp15X683521","article-title":"Cannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice population","volume":"65","author":"J Macleod","year":"2015","journal-title":"Br J Gen Pract"},{"issue":"02","key":"ref36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/M18-0522","article-title":"Marijuana use, respiratory symptoms, and pulmonary function: a systematic review and meta-analysis","volume":"169","author":"M Ghasemiesfe","year":"2018","journal-title":"Ann Intern Med"},{"issue":"01","key":"ref37","first-page":"46","article-title":"Marijuana use associations with pulmonary symptoms and function in Tobacco smokers enrolled in the Subpopulations and Intermediate Outcome Measures in COPD study (SPIROMICS)","volume":"5","author":"M A Morris","year":"2018","journal-title":"Chronic Obstr Pulm Dis (Miami)"},{"issue":"02","key":"ref38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1021\/tx700275p","article-title":"A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions","volume":"21","author":"D Moir","year":"2008","journal-title":"Chem Res Toxicol"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mayocp.2011.10.005","article-title":"Cannabinoid hyperemesis: a case series of 98 patients","volume":"87","author":"D A Simonetto","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"04","key":"ref40","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1161\/STR.0000000000000396","article-title":"Use of marijuana: effect on brain health: a scientific statement From the American Heart Association","volume":"53","author":"F D Testai","year":"2022","journal-title":"Stroke"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12873-021-00428-0","article-title":"Acute cannabis intoxication in the emergency department: the effect of legalization","volume":"21","author":"R Baraniecki","year":"2021","journal-title":"BMC Emerg Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"115680","DOI":"10.1016\/j.socscimed.2023.115680","article-title":"The impact of recreational cannabis markets on motor vehicle accident, suicide, and opioid overdose fatalities","volume":"320","author":"S Marinello","year":"2023","journal-title":"Soc Sci Med"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/CXA.0000000000000046","article-title":"Impact of cannabis use on road traffic collisions and safety at work: systematic review and meta-analysis","volume":"10","author":"C Els","year":"2019","journal-title":"Can J Addict"},{"issue":"07","key":"ref44","doi-asserted-by":"crossref","first-page":"H785","DOI":"10.1152\/ajpheart.00571.2015","article-title":"Endocannabinoids in cerebrovascular regulation","volume":"310","author":"Z Beny\u00f3","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"03","key":"ref45","first-page":"649","article-title":"Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat","volume":"196","author":"M D Adams","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"issue":"03","key":"ref46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrcardio.2017.130","article-title":"Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly","volume":"15","author":"P Pacher","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/pgmj.2008.070425","article-title":"Cannabis and stroke: is there a link?","volume":"85","author":"B R Thanvi","year":"2009","journal-title":"Postgrad Med J"},{"issue":"25","key":"ref48","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1161\/CIRCULATIONAHA.122.062564","article-title":"Cannabis inhalation acutely reduces muscle sympathetic nerve activity in humans","volume":"146","author":"C P Cheung","year":"2022","journal-title":"Circulation"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"323706","DOI":"10.1155\/2015\/323706","article-title":"Tetrahydrocannabinol induces brain mitochondrial respiratory chain dysfunction and increases oxidative stress: a potential mechanism involved in cannabis-related stroke","volume":"2015","author":"V Wolff","year":"2015","journal-title":"BioMed Res Int"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM197407112910203","article-title":"Effect of marihuana and placebo-marihuana smoking on angina pectoris","volume":"291","author":"W S Aronow","year":"1974","journal-title":"N Engl J Med"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/mp.2008.50","article-title":"Heavy marijuana users show increased serum apolipoprotein C-III levels: evidence from proteomic analyses","volume":"15","author":"S Jayanthi","year":"2010","journal-title":"Mol Psychiatry"},{"issue":"06","key":"ref52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/clc.21962","article-title":"Cannabinoids and atherosclerotic coronary heart disease","volume":"35","author":"S Singla","year":"2012","journal-title":"Clin Cardiol"},{"issue":"04","key":"ref53","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1213\/01.ANE.0000131505.03006.74","article-title":"The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets","volume":"99","author":"E Deusch","year":"2004","journal-title":"Anesth Analg"},{"issue":"02","key":"ref54","first-page":"146","article-title":"The cardiovascular effects of marijuana: are the potential adverse effects worth the high?","volume":"116","author":"V N Subramaniam","year":"2019","journal-title":"Mo Med"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1212\/01.WNL.0000150882.69371.DD","article-title":"Cerebrovascular perfusion in marijuana users during a month of monitored abstinence","volume":"64","author":"R I Herning","year":"2005","journal-title":"Neurology"},{"issue":"02","key":"ref56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-0447.1992.tb03247.x","article-title":"Middle cerebral artery velocity during upright posture after marijuana smoking","volume":"86","author":"R J Mathew","year":"1992","journal-title":"Acta Psychiatr Scand"},{"issue":"09","key":"ref57","first-page":"e5607","article-title":"Arrhythmia-related hospitalization and comorbid cannabis use disorder: trend analysis in US hospitals (2010-2014)","volume":"11","author":"P R Jaladi","year":"2019","journal-title":"Cureus"},{"issue":"22","key":"ref58","doi-asserted-by":"crossref","first-page":"e011200","DOI":"10.1161\/JAHA.118.011200","article-title":"Stroke risk period after acute myocardial infarction revised","volume":"7","author":"J Putaala","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"05","key":"ref59","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/1747493019895651","article-title":"Stroke in young cannabis users (18-49 years): national trends in hospitalizations and outcomes","volume":"15","author":"R Desai","year":"2020","journal-title":"Int J Stroke"},{"issue":"07","key":"ref60","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1360-0443.2012.03837.x","article-title":"The co-occurring use and misuse of cannabis and tobacco: a review","volume":"107","author":"A Agrawal","year":"2012","journal-title":"Addiction"},{"issue":"04","key":"ref61","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archpsyc.64.4.495","article-title":"Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients","volume":"64","author":"A N Westover","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jns.2016.01.066","article-title":"Recreational marijuana use and acute ischemic stroke: a population-based analysis of hospitalized patients in the United States","volume":"364","author":"K Rumalla","year":"2016","journal-title":"J Neurol Sci"},{"issue":"03","key":"ref63","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/1753-6405.12477","article-title":"Heavy cannabis users at elevated risk of stroke: evidence from a general population survey","volume":"40","author":"D Hemachandra","year":"2016","journal-title":"Aust N Z J Public Health"},{"issue":"03","key":"ref65","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/jcbfm.2014.218","article-title":"Cannabinoids in experimental stroke: a systematic review and meta-analysis","volume":"35","author":"T J England","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"09","key":"ref66","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1161\/STROKEAHA.118.023587","article-title":"Cannabis and cannabinoid biology in stroke","volume":"50","author":"S H Choi","year":"2019","journal-title":"Stroke"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neulet.2014.03.077","article-title":"The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in rats","volume":"569","author":"J R Rivers-Auty","year":"2014","journal-title":"Neurosci Lett"},{"issue":"10","key":"ref68","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S1474-4422(12)70135-7","article-title":"Reversible cerebral vasoconstriction syndrome","volume":"11","author":"A Ducros","year":"2012","journal-title":"Lancet Neurol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.yebeh.2017.01.031","article-title":"Strokes are possible complications of cannabinoids use","volume":"70","author":"V Wolff","year":"2017","journal-title":"Epilepsy Behav"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/brain\/awm256","article-title":"The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients","volume":"130","author":"A Ducros","year":"2007","journal-title":"Brain"},{"issue":"06","key":"ref71","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1161\/STROKEAHA.110.610915","article-title":"Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients","volume":"42","author":"V Wolff","year":"2011","journal-title":"Stroke"},{"issue":"01","key":"ref73","first-page":"32","article-title":"The epidemiology of reversible cerebral vasoconstriction syndrome in patients at a Colorado comprehensive stroke center","volume":"10","author":"J Jensen","year":"2018","journal-title":"J Vasc Interv Neurol"},{"issue":"12","key":"ref74","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.011","article-title":"Association and clinical outcomes of marijuana in patients with intracerebral hemorrhage","volume":"27","author":"K Malhotra","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000443532","article-title":"Prior cannabis use is associated with outcome after intracerebral hemorrhage","volume":"41","author":"M Di Napoli","year":"2016","journal-title":"Cerebrovasc Dis"},{"issue":"01","key":"ref76","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12916-020-01804-6","article-title":"Cannabis use disorder and the future risk of cardiovascular disease in parous women: a longitudinal cohort study","volume":"18","author":"N Auger","year":"2020","journal-title":"BMC Med"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2016.10.016","article-title":"Cannabinoid receptor 2 activation restricts fibrosis and alleviates hydrocephalus after intraventricular hemorrhage","volume":"1654","author":"Q Tan","year":"2017","journal-title":"Brain Res"},{"issue":"02","key":"ref78","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.019","article-title":"Association of recreational marijuana use with aneurysmal subarachnoid hemorrhage","volume":"25","author":"K Rumalla","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1016\/j.wneu.2021.07.079","article-title":"Cannabis use and increased nonaneurysmal subarachnoid hemorrhage in the past decade","volume":"154","author":"P MR Lai","year":"2021","journal-title":"World Neurosurg"},{"issue":"02","key":"ref80","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1161\/STROKEAHA.121.035650","article-title":"Cannabis use and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"53","author":"J S Catapano","year":"2022","journal-title":"Stroke"},{"issue":"05","key":"ref81","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/STROKEAHA.116.013099","article-title":"Cannabis use and outcomes in patients with aneurysmal subarachnoid hemorrhage","volume":"47","author":"R Behrouz","year":"2016","journal-title":"Stroke"},{"issue":"08","key":"ref82","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1161\/STROKEAHA.122.038951","article-title":"Cannabis use is not associated with aneurysmal subarachnoid hemorrhage complications or outcomes","volume":"53","author":"F Akbik","year":"2022","journal-title":"Stroke"},{"issue":"03","key":"ref83","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12975-022-01080-x","article-title":"Cannabidiol's multifactorial mechanisms has therapeutic potential for aneurysmal subarachnoid hemorrhage: a review","volume":"14","author":"N Henry","year":"2023","journal-title":"Transl Stroke Res"},{"issue":"10","key":"ref84","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1192\/bjp.131.4.361","article-title":"Cannabis and the peripheral nervous system","volume":"131","author":"M DiBenedetto","year":"1977","journal-title":"Br J Psychiatry"},{"issue":"23","key":"ref85","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1523\/JNEUROSCI.21-23-09506.2001","article-title":"Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission","volume":"21","author":"I Katona","year":"2001","journal-title":"J Neurosci"},{"issue":"04","key":"ref86","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1037\/pha0000326","article-title":"Cognitive outcomes associated with long-term, regular, recreational cannabis use in adults: a meta-analysis","volume":"28","author":"M E Lovell","year":"2020","journal-title":"Exp Clin Psychopharmacol"},{"issue":"47","key":"ref87","doi-asserted-by":"crossref","first-page":"16913","DOI":"10.1073\/pnas.1415297111","article-title":"Long-term effects of marijuana use on the brain","volume":"111","author":"F M Filbey","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"ref88","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1523\/JNEUROSCI.1165-19.2019","article-title":"Cannabis and the developing brain: Insights into its long-lasting effects","volume":"39","author":"Y L Hurd","year":"2019","journal-title":"J Neurosci"},{"issue":"07","key":"ref89","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/0020764018801690","article-title":"Cannabis consumption and psychosis or schizophrenia development","volume":"64","author":"M B Ortiz-Medina","year":"2018","journal-title":"Int J Soc Psychiatry"},{"issue":"06","key":"ref90","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archgenpsychiatry.2011.5","article-title":"Cannabis use and earlier onset of psychosis: a systematic meta-analysis","volume":"68","author":"M Large","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"03","key":"ref91","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(14)00117-5","article-title":"Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study","volume":"2","author":"M Di Forti","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"02","key":"ref92","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/aje\/kwq096","article-title":"Early cannabis use and estimated risk of later onset of depression spells: epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative","volume":"172","author":"R de Graaf","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"04","key":"ref93","doi-asserted-by":"crossref","first-page":"e202370","DOI":"10.1001\/jamanetworkopen.2020.2370","article-title":"Prevalence of cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: a systematic review and meta-analysis","volume":"3","author":"A Bahji","year":"2020","journal-title":"JAMA Netw Open"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/SAR.S109576","article-title":"The cannabis withdrawal syndrome: current insights","volume":"8","author":"U Bonnet","year":"2017","journal-title":"Subst Abuse Rehabil"},{"issue":"07","key":"ref95","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/add.15743","article-title":"Clinical management of cannabis withdrawal","volume":"117","author":"J P Connor","year":"2022","journal-title":"Addiction"},{"issue":"06","key":"ref96","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1530\/REP-16-0167","article-title":"Endocannabinoid system and pregnancy","volume":"152","author":"F Correa","year":"2016","journal-title":"Reproduction"},{"issue":"02","key":"ref97","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.2019.8734","article-title":"Association between self-reported prenatal cannabis use and maternal, perinatal, and neonatal outcomes","volume":"322","author":"D J Corsi","year":"2019","journal-title":"JAMA"},{"issue":"04","key":"ref98","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2217\/fnl.11.27","article-title":"Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain","volume":"6","author":"C S Wu","year":"2011","journal-title":"Future Neurol"},{"issue":"01","key":"ref99","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jamapsychiatry.2020.2902","article-title":"Associations between prenatal cannabis exposure and childhood outcomes: results from the ABCD study","volume":"78","author":"S E Paul","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"40","key":"ref100","doi-asserted-by":"crossref","first-page":"E2657","DOI":"10.1073\/pnas.1206820109","article-title":"Persistent cannabis users show neuropsychological decline from childhood to midlife","volume":"109","author":"M H Meier","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"03","key":"ref101","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1503\/cmaj.130510","article-title":"Synthetic cannabinoids","volume":"186","author":"T Antoniou","year":"2014","journal-title":"CMAJ"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.drugalcdep.2012.12.011","article-title":"Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample","volume":"131","author":"A R Winstock","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"07","key":"ref103","doi-asserted-by":"crossref","first-page":"e208516","DOI":"10.1001\/jamanetworkopen.2020.8516","article-title":"Critical illness secondary to synthetic cannabinoid ingestion","volume":"3","author":"I Kourouni","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"10","key":"ref104","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1176\/appi.ajp.2011.11010176","article-title":"Psychosis associated with synthetic cannabinoid agonists: a case series","volume":"168","author":"D Hurst","year":"2011","journal-title":"Am J Psychiatry"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"e936209","DOI":"10.12659\/AJCR.936209","article-title":"A case of synthetic cannabinoid (K2)-induced posterior reversible encephalopathy syndrome (PRES)","volume":"23","author":"H Ghazanfar","year":"2022","journal-title":"Am J Case Rep"},{"issue":"04","key":"ref106","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/20009666.2020.1781349","article-title":"Man vs. man-made marijuana: a case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB)","volume":"10","author":"P Parajuli","year":"2020","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref107","first-page":"120607","article-title":"A unique case of cardiac arrest following K2 abuse","volume":"2014","author":"S Ibrahim","year":"2014","journal-title":"Case Rep Cardiol"},{"issue":"10","key":"ref108","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1016\/j.hlc.2015.04.176","article-title":"Teenage cardiac arrest following abuse of synthetic cannabis","volume":"24","author":"C Davis","year":"2015","journal-title":"Heart Lung Circ"}],"container-title":["Seminars in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1787570.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T09:49:46Z","timestamp":1730800186000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1787570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":102,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,7,16]]},"published-print":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1787570","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0271-8235","1098-9021"],"issn-type":[{"value":"0271-8235","type":"print"},{"value":"1098-9021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,24]]}}}